Revenue grew ~41% YoY to | 148 crore led by a ramp up of new products in the healthcare and toy segment. Volumes were up ~20% YoY The EBITDA margin declined 381 bps YoY to 14.1%, mainly due to a delay in passing on high raw material costs and higher other expenditure PAT increased 16% YoY to ~ | 9 crore, tracking sales growth...